Delonghi PAC-WE130
Matthew Plavan, who has served as the RanchioCordova company’s (Nasdaq: KOOL) interim CEO sincde December, has become the chievf operating officer. He will retain his titles of executive vice presidenty and chief financial officer of the which makes devices for storing and processinfg stem cells andblood products. “Mel has servex as president and CEO of threw healthcare companies, as well as having extensives management experience in finance, sales and international market development with both large and smalp device and pharmaceutical organizations,” said Patricj McEnany, director and chairman of the company’s governance and nominatingh committee, in a news release.
“After conducting an extensived search and interviewing a numbed ofexcellent candidates, it was clear to the boardr that Mel’s wide-ranging health care industryg experience made him a great fit for ThermoGenesis.” Engle’xs last job was CEO of , a lasetr technology company. Before that he spent six yearx as president and CEOof , a $600 milliomn specialty pharmaceutical company affiliated with Merckj KGaA. Prior to that he was chairman, presidengt and CEO of , a small, publiclh traded medical device company.
Engle’s has also workecd as regional director in North America for and held seniofr management positions with He is a member of the boared of directorsof (OTCBB: OXBO), formerly knowb as , which is developingv oxygen-delivery therapies. He has a bachelor’s degree in accountingb from the University of Colorado anda master’s degrew in business administration with a specialty in finance from the University of Southern California. “I am excited to be joining particularly at a time of heightened interest in and growinh awareness of the therapeutic value of stem Engle said in thenews release.
“ThermoGenesis possessez a strong technology base with a dedicatede and knowledgeable group of It is well positioned to capitalize on the growing stemcell market. ThermoGenesis has a traclk record of product innovation and is on the cusp of realizing an increasexd market presence with its current andnew offerings.” “j appreciate the support of our board and employees over the past several months and look forward to working with Mel on a furthefr implementation of our turnaround strategy,” Plavan said in the news
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment